Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Link opens in a new tab
Search content at University of Birmingham
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Antithrombotic dose: some observations from published clinical trials
Simon Dimmitt
, Christopher Floyd
,
Robin Ferner
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antithrombotic dose: some observations from published clinical trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Trials
100%
Randomized Controlled Trial
100%
Clinical Practice
33%
Preclinical Data
33%
Placebo
33%
Aspirin
33%
Clinical Data
33%
Atrial Fibrillation
33%
Stroke Risk
33%
Warfarin
33%
Antiplatelet Agents
33%
Clopidogrel
33%
Coronary Disease
33%
Non-inferiority
33%
Anticoagulant Agents
33%
Direct Oral Anticoagulants
33%
Clinical Dose
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Anticoagulant Agent
100%
Randomized Controlled Trial
60%
Placebo
20%
Cerebrovascular Accident
20%
Ischemic Heart Disease
20%
Coronary Artery Disease
20%
Atrial Fibrillation
20%
Acetylsalicylic Acid
20%
Warfarin
20%
Antithrombocytic Agent
20%
Clopidogrel
20%
Direct Oral Anticoagulant
20%
Low Drug Dose
20%